Pathology of resolving polyomavirus-associated nephropathy

American Journal of Transplantation

Volumn 13, Issue 6, 2013, Pages 1474-1483

  Menter, T ^a   Mayr, M ^b   Schaub, S ^b   Mihatsch, M J ^a   Hirsch, H H ^b,c   Hopfer, H ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Allograft rejection; biopsies; BK virus; immunohistochemistry; immunosuppression; polyoma; polyomavirus associated nephropathy; surveillance; SV40

Indexed keywords

HLA DR ANTIGEN;

ADULT; AGED; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY INTERSTITIUM; LYMPHOCYTE; MALE; NEPHRITIS; NONHUMAN; POLYOMAVIRUS BK ASSOCIATED NEPHROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIREMIA; VIRUS LOAD;

EID: 85027916922     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12218     Document Type: Article

References (34)

1. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594.
2. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirusassociated nephropathy (PVAN). Am J Transplant 2006; 6: 1025-1032.
3. Hardinger KL, Koch MJ, Bohl DJ, Storch GA, Brennan DC. BK-virus and the impact of pre-emptive immunosuppression reduction: 5- year results. Am J Transplant 2010; 10: 407-415.
4. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10: 2615-2623.
5. Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: A prospective, randomized, multicenter study. Am J Transplant 2013; 13: 136-145.
6. Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 2009; 87: 621-630.
7. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirusassociated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277-1286.
8. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488-496.
9. Hirsch HH, Randhawa P. BK virus in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl. 4): S136-S146.
10. Kuypers DRJ. Management of polyomavirus-associated nephropathy in renal transplant recipients. Nat Rev Nephrol 2012; 8: 390-402.
11. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315.
12. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082-2092.
13. Gaber LW, Egidi MF, Stratta RJ, Lo A, Moore LW, Gaber AO. Clinical utility of histological features of polyomavirus allograft nephropathy. Transplantation 2006; 82: 196-204.
14. Sar A, Worawichawong S, Benediktsson H, Zhang J, Yilmaz S, Trpkov K. Interobserver agreement for Polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology. Hum Pathol 2011; 42: 2018-2024.
15. Nishi S. Polyomavirus nephropathy-Recent pathological diagnostic problems and the report from the 2011 Banff meeting. Clin Transplant 2012; 26 (Suppl. 24): 9-12.
16. Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Treatment of polyomavirus infection in kidney transplant recipients: A systematic review. Transplantation 2010; 89: 1057-1070.
17. Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008; 13: 569-574.
18. Comoli P, Azzi A, Maccario R, et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004; 78: 1229-1232.
19. Binggeli S, Egli A, Schaub S, et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007; 7: 1131-1139.
20. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7: 2727-2735.
21. Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S. Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation 2008; 85: 185-192.
22. Schachtner T, Müller K, Stein M, et al. BK virus-specific immunity kinetics: A predictor of recovery from polyomavirus BK-associated nephropathy. Am J Transplant 2011; 11: 2443-2452.
23. Schaub S, Mayr M, Egli A, et al. Transient allograft dysfunction from immune reconstitution in a patient with polyoma BK-virusassociated nephropathy. Nephrol Dial Transplant 2007; 22: 2386-2390.
24. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184: 1494-1495; author reply 1495-1496.
25. Sis B, Mengel M, Haas M, et al. Banff'09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
26. Kemény E, Hirsch HH, Eller J, Dürmüller U, Hopfer H, Mihatsch MJ. Plasma cell infiltrates in polyomavirus nephropathy. Transpl Int 2010; 23: 397-406.
27. Meehan SM, Kadambi PV, Manaligod JR, Williams JW, Josephson MA, Javaid B. Polyoma virus infection of renal allografts: Relationships of the distribution of viral infection, tubulointerstitial inflammation, and fibrosis suggesting viral interstitial nephritis in untreated disease. Hum Pathol 2005; 36: 1256-1264.
28. McGilvray ID, Lajoie G, Humar A, Cattral MS. Polyomavirus infection and acute vascular rejection in a kidney allograft: Coincidence or mimicry? Am J Transplant 2003; 3: 501-504.
29. Womer KL, Guerra G, Dibadj K, et al. Immunosuppression reduction for BK virus nephropathy: A case for caution. Transpl Infect Dis 2007; 9: 244-248.
30. Batal I, Zainah H, Stockhausen S, et al. The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy. Mod Pathol 2009; 22: 1468-1476.
31. Atsumi H, Asaka M, Kimura S, et al. A case of second renal transplantation with acute antibody-mediated rejection complicated with BK virus nephropathy. Clin Transplant 2010; 24 (Suppl. 22): 35-38.
32. Tanabe T, Shimizu T, Sai K, et al. BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: A case report. Clin Transplant 2011; 25 (Suppl. 23): 39-43.
33. Masutani K, Zeng G, Randhawa P. Severe acute T cell and antibody-mediated rejection in ectopic kidney allografts with or without mouse polyomavirus infection. Am J Transplant 2012; 12: 3161-3162.
34. Batal I, Franco ZM, Shapiro R, et al. Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. Hum Pathol 2009; 40: 1312-1319.